Phreesia - יחס שווי כולל של החברה להכנסות PHR

The Enterprise Value to Sales ratio demonstrates the high resilience of Phreesia, Inc. (PHR) to crises, as medical traffic remains independent of the economy, with the latest reading standing at 1441.13. Revenue stability is driven by cloud subscriptions and broad coverage across medical specialties. Business development relies on the digitalization of patient registration and the automation of clinic financial settlements to increase efficiency.
PHR (Phreesia): פילוחים אנליטיים ודוחות לפי אינדיקטורים

The EV/Sales metric determines the total value of the business, including debt, relative to a unit of revenue. A decline in this ratio often signals that an asset is undervalued relative to its operating income. By analyzing the market value-to-revenue ratio, an investor can identify market distortions. For Phreesia, Inc. (PHR), this indicator reflects market expectations regarding the scaling of SaaS services. High values are justified by the clinic automation platform's transition to a stage of stable monetization.